Insulet PODD
NASDAQ PODD
$134.69 -3.23 (-2.34%)
As of: Sep 10, 2026 · 2:07 PM EDT

Insulet (PODD) Income from Discontinued Operations (2015 - 2016)

Insulet's (PODD) quarterly Income from Discontinued Operations came in at $34000.0 in Q4 2016, up 100.3% on a YoY basis from $16974.7 in Q1 2016, and up 153.12% quarter-over-quarter from -$64000.0 in Q3 2016.

Analysis

Insulet (PODD) Income from Discontinued Operations (2015 - 2016) Analysis & Trends

Insulet (PODD) has reported Income from Discontinued Operations for 2 consecutive years, with $34000.0 the latest figure, recorded in Q4 2016.

  • For the quarter ending Q4 2016, Income from Discontinued Operations rose 100.3% year-over-year to $34000.0; the trailing twelve-month figure through Sep 2017 stood at $34000.0 (up 100.26% YoY), and the FY2016 full-year result was -$1.7 million, up 85.74% from the prior year.
  • Income from Discontinued Operations grew to $34000.0 in Q4 2016 per PODD's latest filing, from -$64000.0 in the prior quarter.
  • Across five years, Income from Discontinued Operations topped out at $1.8 million in Q2 2015 and bottomed at -$11.4 million in Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Abbott Laboratories 180.76 Bn 175.16 Bn 7.27 Bn -
2 Intuitive Surgical 127.32 Bn 122.10 Bn 1.96 Bn -
3 Medtronic 116.90 Bn 108.08 Bn 6.34 Bn -
4 Stryker 103.97 Bn 100.50 Bn 4.50 Bn -
5 Boston Scientific 63.66 Bn 63.12 Bn 3.85 Bn -
6 Edwards Lifesciences 49.73 Bn 45.48 Bn 1.35 Bn -
7 Alcon 33.00 Bn 31.54 Bn 1.68 Bn -
8 Dexcom 32.04 Bn 30.09 Bn 830.00 Mn -
9 Steris 20.70 Bn 20.22 Bn 684.20 Mn -
10 Insulet 9.33 Bn 8.80 Bn 562.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 34,000.00
Sep 30, 2016 -64,000.00
Jun 30, 2016 153,000.00
Mar 31, 2016 -1.79 Mn
Dec 31, 2015 -11.42 Mn
Sep 30, 2015 -943,000.00
Jun 30, 2015 1.84 Mn
Mar 31, 2015 -1.39 Mn